As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

Schlegel's academic journey later brought him to two of the world's most respected institutions for technological research: ...

ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema in adult and pediatric patients 12 years and older. One capsule of ...

The use of NMR technology is on the rise in the food industry, as this technology is helpful in a broad range of activities, ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

All wines have some volatile acidity, which can add to a wine’s complexity at low levels. At what point does it become a ...

Primary aldosteronism treatment response was associated with higher plasma renin activity and serum potassium levels and lower aldosterone.

When using high-flow nasal cannula (HFNC), setting a higher flow rate of 60 vs 40 L/min for post-extubation care did not improve key outcomes.

SK pharmteco, a global contract development and manufacturing organization (CDMO), has launched an enhanced analytical testing laboratory specifically dedicated to High Potency Active Pharmaceutical ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Raymond James analyst Steven Seedhouse raised the firm’s price target on Viking Therapeutics (VKTX) to $125 from $122 and keeps a Strong Buy ...